Product Information
OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.2308 per EA under NDC 10702018750. Its NADAC has been published 399 times since Feb 13, 2019.
FDA first approved this application on Feb 9, 2018. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Oxycodone and Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
325; 10 mg/1; mg/1
Manufacturer
KVK-Tech Inc.NDC
10702018750
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; OXYCODONEApproval Type
Generic (ANDA)
FDA Application
ANDA210644FDA Approved
2/9/2018
TE Code
AA
On Market Since
2/9/2018
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has been published 399 times since Feb 13, 2019, and over the history we have for it it has declined 17.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2308 per EA |
|---|---|
| All-time high | $0.3021 (Aug 14, 2019) |
| All-time low | $0.1580 (Sep 22, 2021) |
| 52-week high | $0.2472 |
| 52-week low | $0.2292 |
| Median price | $0.2184 |
| Average price | $0.2211 |
| Largest weekly change | -22.1% (Nov 20, 2024) |
| Weeks tracked | 399 |
| Tracking since | Feb 13, 2019 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
KVK-Tech Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxycodone and Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET, manufactured by KVK-Tech Inc., is $0.2308 per EA (NDC 10702018750), effective Sep 30, 2026.
How has the price of OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has declined 17.6%. It has been tracked across 399 weekly CMS publications since Feb 13, 2019.
What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
Since Feb 13, 2019, the NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has ranged from a low of $0.1580 (Sep 22, 2021) to a high of $0.3021 (Aug 14, 2019), with a median of $0.2184 per EA.
Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET, is $0.1796 per EA — about 22% below OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET.
Who manufactures OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET (NDC 10702018750) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.